Integrated CRO alliances growing but poorly executed

Results from a new CenterWatch survey show CROs generally believe that while the prevalence of integrated alliances with sponsors will grow in the next three to five years, many sponsors fall short when managing these more sophisticated relationships. In the survey, the first to measure how well sponsors are handling these newer forms of outsourcing relationships, CROs generally gave those companies with more strategic, integrated relationships higher “good/excellent” ratings than those in traditional transactional relationships. Analysis suggests that while many sponsors want to form integrated alliances, many are struggling with how to leverage...

Sites tackle the financial challenges of industry change

Between the weak economy and consolidation in the pharmaceutical industry, investigative sites continue to struggle to make ends meet. They cite the dearth of high-quality studies and increasing sponsor attempts to push costs along to the site level, as well as ongoing difficulty with collecting payments in a timely manner. To weather the storm, sites are marketing themselves more aggressively and becoming more efficient financial managers by

Eye On Cephalon

Cephalon describes itself as “a global biopharmaceutical company driven to expand the boundaries of science to improve human health… with first-in-class therapeutics” since it was founded in 1987 as a biotech startup. Through its diverse research pipeline and approved medications in Oncology, Neurology (including pain control), Immunology and Cardiology, Cephalon has become one of the world’s... 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.